CONMED CORP
CNMDNYSE🏆 #2243 by market capEarnings Oct 28 · PostUS Equity
$46.69▲ $0.21 (+0.45%)
Market closed · at closeTrack CNMD
Get earnings, price moves & breaking news on Telegram
24h▲ 0.5%
7d▲ 1.8%
14d▼ 0.9%
30d▼ 6.2%
ytd▲ 15.0%
1y▼ 0.7%
🏦Market Cap
$1.40B
Small Cap
📈Revenue Growth (YoY)
+3.4%
Slowing
📊Gross Margin
55.8%
Healthy
💵FCF Margin
9.8%
Moderate
⚖️P/S Ratio
1.0x
Cheap
Otter Score
72
Fair
CONMED CORP
CNMDAnalyst Ratings
Price
$46.69
Total
21
Raised
1
Lowered
6
Avg PT
$37.50
H / L
$39 / $36
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Piper Sandler | Reiterated | Neutral | 2026-07-30 | $95.00 | +103.50% |
Wells Fargo | Reiterated | Equal Weight | 2026-07-30 | $39.00 | −16.50% |
B of A Securities | Downgraded | Neutral → Underperform | 2026-06-29 | — | — |
JP Morgan | Reiterated | Neutral | 2026-04-30 | — | — |
Needham | Reiterated | Hold | 2026-01-29 | $61.00 | +30.60% |
Stifel | Downgraded | Buy → Hold | 2025-04-28 | — | — |
Keybanc | Reiterated | Overweight | 2023-07-27 | — | — |
CL King | Reiterated | Buy | 2023-05-22 | — | — |
Jefferies | Reiterated | Hold | 2022-10-12 | — | — |
UBS | Reiterated | Buy | 2021-07-15 | — | — |
Barclays | Reiterated | Overweight | 2021-05-25 | — | — |
SVB Leerink | Reiterated | Market Perform | 2020-07-30 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2019-10-31 | — | — |
Piper Jaffray | Upgraded | Neutral → Overweight | 2019-08-22 | — | — |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2017-04-27 | — | — |
Leerink Swann | Downgraded | Outperform → Market Perform | 2016-07-28 | — | — |
Northland Capital Markets | Downgraded | Outperform → Market Perform | 2015-07-22 | — | — |
Northland Securities | Downgraded | Outperform → Market Perform | 2015-07-22 | — | — |
Deutsche Bank | Reiterated | Buy | 2015-05-04 | — | — |
PiperJaffray | Reiterated | Neutral | 2015-04-23 | — | — |
KeyBanc | Reiterated | Sector Weight → Equal Weight | 2015-03-16 | — | — |
Institution
Piper Sandler
Reiterated · Neutral · 2026-07-30
$95.00
+103.50%
Wells Fargo
Reiterated · Equal Weight · 2026-07-30
$39.00
−16.50%
B of A Securities
Downgraded · Neutral → Underperform · 2026-06-29
—
—
JP Morgan
Reiterated · Neutral · 2026-04-30
—
—
Needham
Reiterated · Hold · 2026-01-29
$61.00
+30.60%
Stifel
Downgraded · Buy → Hold · 2025-04-28
—
—
Keybanc
Reiterated · Overweight · 2023-07-27
—
—
CL King
Reiterated · Buy · 2023-05-22
—
—
Jefferies
Reiterated · Hold · 2022-10-12
—
—
UBS
Reiterated · Buy · 2021-07-15
—
—
Barclays
Reiterated · Overweight · 2021-05-25
—
—
SVB Leerink
Reiterated · Market Perform · 2020-07-30
—
—
Stifel Nicolaus
Reiterated · Buy · 2019-10-31
—
—
Piper Jaffray
Upgraded · Neutral → Overweight · 2019-08-22
—
—
Ladenburg Thalmann
Downgraded · Buy → Neutral · 2017-04-27
—
—
Leerink Swann
Downgraded · Outperform → Market Perform · 2016-07-28
—
—
Northland Capital Markets
Downgraded · Outperform → Market Perform · 2015-07-22
—
—
Northland Securities
Downgraded · Outperform → Market Perform · 2015-07-22
—
—
Deutsche Bank
Reiterated · Buy · 2015-05-04
—
—
PiperJaffray
Reiterated · Neutral · 2015-04-23
—
—
KeyBanc
Reiterated · Sector Weight → Equal Weight · 2015-03-16
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space